Craft

NexgenRx

Stock Price

$0.3

2024-10-29

Market Capitalization

$19.5 M

2024-10-29

Revenue

$17.9 M

FY, 2025

NexgenRx Summary

Company Summary

Overview
NexgenRx is a company that provides ASO (self-funded) drug, dental and extended health benefit plans supported by technology. It develops and operates a claims adjudication system along with a health care provider portal for real-time claim submissions and processing. The Company's services include full benefits administration, health and dental claims adjudication, pharmacy benefit manager, health care spending accounts, taxable spending accounts, flexible benefits, etc.
Type
Public
Status
Active
Founded
2003
HQ
Toronto, CA | view all locations
Website
http://en.nexgenrx.com/
Cybersecurity rating
Sectors

Key People

  • Ronald C. Loucks

    Ronald C. Loucks, Founder, President & CEO, Director

    • Kelly Elher

      Kelly Elher, CFO

      • Andrew Munroe

        Andrew Munroe, Director Operations

        • Paul Freedman

          Paul Freedman, Medical Director

          LocationsView all

          2 locations detected

          • Toronto, ON HQ

            Canada

            185 The West Mall Suite 600, Etobicoke

          • Toronto, ON

            Canada

            145 The West Mall, Etobicoke

          NexgenRx Financials

          Summary Financials

          Revenue (FY, 2025)
          $C17.9M
          Gross profit (FY, 2025)
          $C14.9M
          Net income (FY, 2025)
          $C1.3M
          Cash (FY, 2025)
          $C4.8M
          EBIT (FY, 2025)
          $C2.1M

          Footer menu